[A case of triple A syndrome with c.463C>T mutation in the AAAS gene]

Rinsho Shinkeigaku. 2022 Sep 28;62(9):740-743. doi: 10.5692/clinicalneurol.cn-001743. Epub 2022 Aug 26.
[Article in Japanese]

Abstract

A 47-year-old woman was admitted to our hospital for scrutiny of limb weakness and orthostatic hypotension that had progressed from childhood. She had been treated for alacrima and esophageal achalasia from childhood. On admission, she had hyperreflexia of upper and lower extremities, distal predominant muscle atrophy in the lower extremities, decreased sensation of the distal extremities, and autonomic neuropathy. Her blood test results ruled out adrenal insufficiency, but Schirmer's test was positive. Given the lacrimation symptoms, esophageal achalasia, and neuropathy, the patient was diagnosed with triple A syndrome in whom a c.463C>T mutation (p.R155C) was found in the AAAS gene by genetic testing. Triple A syndrome is an autosomal recessive inherited disease caused by mutations in the AAAS gene. Genetic testing of the AAAS gene should be considered in patients with one or two of main symptoms of triple A syndrome.

Keywords: achalasia; alacrima; triple A syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Insufficiency* / diagnosis
  • Adrenal Insufficiency* / genetics
  • Child
  • Esophageal Achalasia* / diagnosis
  • Esophageal Achalasia* / genetics
  • Female
  • Humans
  • Middle Aged
  • Mutation
  • Nerve Tissue Proteins / genetics
  • Nuclear Pore Complex Proteins / genetics

Substances

  • AAAS protein, human
  • Nerve Tissue Proteins
  • Nuclear Pore Complex Proteins

Supplementary concepts

  • Achalasia Addisonianism Alacrimia syndrome